Alex Kolicich
Founding Partner @ 8VC
San Francisco, United States
Alex Kolicich is a Founding Partner at 8VC. Prior to joining 8VC, Alex was a Sr. Partner at Formation 8. Alex has also worked with Peter Thiel as a Principal at Mithril Capital Management, a growth-stage venture fund, where he helped lead investments in AppDirect, C2FO, and Helion Energy.Preceding his venture career, Alex worked as an engineerand early-product advisor at Clarium, Palantir, and Google. He was an early member of the Clarium Capital quantitative engineering team (with Joe Lonsdale) and a close advisor/collaborator with the early Palantir team; advising on product design and contributing to the product. At Google Research, Alex worked on Google Street Views before and during the launch. Preceding Street-Views, also at Google, he worked on the development and launch of the Google Checkout product.Alex holds a B.SE. degree from the University of Waterloo and an MA from the University of Toronto.
- Total investments:
- 30
- Last investment:
- Lead investor:
- 30%
Last updated:
For AI agents: llms.txt
Industries Alex Kolicich invests in
Stages Alex Kolicich invests in
Countries Alex Kolicich invests in
Investment Focus
Industry
- Artificial Intelligence 4 (13%)
- Software 3 (10%)
- Health Care 2 (7%)
- Biotechnology 2 (7%)
- Machine Learning 2 (7%)
Stage
- Series A 6 (20%)
- Seed 4 (13%)
- Series B 3 (10%)
- Funding Round 3 (10%)
- Series C 2 (7%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Saris AI is an artificial intelligence company that builds agent-based workflow automation systems for financial institutions, particularly banks and credit unions. The company develops AI “agents” that handle back-office operations such as lending workflows, document processing, compliance checks, data extraction, and internal operational tasks.Its platform integrates directly with existing banking systems like core banking software and loan origination systems, allowing institutions to automate processes without replacing their current infrastructure. The system is designed to reduce manual workload by executing multi-step workflows such as data validation, case handling, and administrative processing while keeping humans in control of approvals and oversight.Saris AI focuses on improving operational efficiency by reducing processing costs and increasing output capacity through automation of repetitive and rules-based tasks. The company positions its technology as a way for financial institutions to streamline operations, improve compliance tracking, and enhance customer service responsiveness. | $28.8M / Series A / May 28, 2026 | |
|
|
Alloy Therapeutics makes medicine by democratizing access to foundational drug discovery platforms and services. Alloy-Gx, its first platform, is a royalty-free suite of immunocompetent transgenic mice enabling best-in-class in vivo human antibody discovery. Founded in 2017, Alloy Therapeutics is headquartered in Lexington, Massachusetts. | $40M / Series E / Apr 15, 2026 | |
|
|
Ritten delivers a platform that helps clinicians and administrators provide personalized, data-informed care. The company's platform offers customized workflow configurations that help to deliver complex treatment consistently and compliantly, enabling clinicians and administrators to maintain a comprehensive patient record that tracks allaspects of a patient's care, including clinical notes, medications, and treatment plans, and deliver personalized, data-informed care. | $35M / Series B / Dec 11, 2025 | |
|
|
Bedrock Robotics delivers enhanced autonomy to the built environment, allowing the construction sector to build at the rate that today's society requires. | $80M / Series A / Jul 16, 2025 | |
|
|
Think it, speak it, send it. Effortless voice dictation for Mac and now Windows! | $30M / Series A / Jun 24, 2025 | |
|
|
Patent discovery, analytics, comparison, and workflow. Simplified via Artificial Intelligence. | $21.1M / Series A / Feb 24, 2025 | |
|
|
Ember Software Schedule, inspect, and report – all you need in one system designed specifically for fire protection organizations. | $10M / Seed / Jan 23, 2025 | |
|
|
Think it, speak it, send it. Effortless voice dictation for Mac and now Windows! | $12M / Venture - Series Unknown / Sep 30, 2024 | |
|
|
PollyEx is a loan trading platform that improves loan sale execution for efficient trading. It offers a cloud-based platform that connects buyers and sellers of mortgage loans through API integration, increasing liquidity, and automating capital market functions. PollyEx was founded in 2019 and is headquartered in San Francisco, California. | $25M / Venture - Series Unknown / Sep 10, 2024 | |
|
|
Patent discovery, analytics, comparison, and workflow. Simplified via Artificial Intelligence. | $4.5M / Seed / Apr 11, 2024 | |
| See all 30 investments → | |||
Co-Investors
About 8VC
8VC is a technology and life sciences investment firm that partners with founders to develop transformational technologies. The firm focuses on creating long-term economic and societal value through its investments across various sectors, including healthcare and logistics.
8VC Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Alex Kolicich
Founding Partner
|
|||
|
David Moskowitz
Principal
|
|||
|
Jack Moshkovich
Principal
|
|||
|
Sebastian Ruales
EIR
|
|||
|
Alex Moore
Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Alex Kolicich invest in?
Alex Kolicich invests primarily in Artificial Intelligence, Software and Health Care startups, most often at Series A and Seed stage. Most of the 30 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Alex Kolicich last invest?
The most recent investment recorded for Alex Kolicich closed in May 2026. Shizune tracks 30 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!